Cholebineによる2,3,4,7,8-Pentachlorodibenzofuran排泄促進
スポンサーリンク
概要
- 論文の詳細を見る
特集号 油症とPCB及びダイオキシン関連化合物 研究報告第22集 責任編集者 古江増隆The Twenty-second Reports of the Study on Yusho―PCBs and Dioxin-Related Compounds―Guest Editor Masutaka FurueWhile it has been reported that the blood level of dioxins and polychlorinated biphenyls in humans may be decreased by treatment with colestimide, the effects of the agent are still obscure. To address this issue, we examined the effect of Cholebine, a cholesterol lowering agent containing colestimide as an active ingredient, on the excretion of 2,3,4,7,8-pentachlorodibenzofuran (PenCDF) in rats. In a short term study, male Wistar rats (5 weeks-old) were given chows including 3% Cholebine (PenCDF/Chol group) or control chows (PenCDF group) for 7 days after administration of 14C-labeled PenCDF (0.5 mg/kg body weight, p.o.). On day 1, the fecal excretion of PenCDF in the PenCDF/Chol group was greater by 15% compared to that of the PenCDF group. Although some increases were also observed during day 2 and day 7, Cholebine did not exhibit any marked effect on the fecal excretion of PenCDF. The tissue concentrations of PenCDF at day 7 in the PenCDF/Chol group showed a 20%.30% decrease compared with those of the PenCDF group, except that the level in the brain was comparable between the two groups. The fecal excretion of PenCDF in a long term study (Cholebine treatment for 28 days) demonstrated the same tendency as that of short term study. However, in long term study, the Cholebine had no effect on the tissue concentration of PenCDF except for brain. An increase in PenCDF excretion by Cholebine seems to be due to the binding of Cholebine to bile acids as lipid carriers. This is because no binding of Cholebine to 14C-PenCDF was detected. These results suggest that Cholebine has little effect on the reabsorption of dioxin, whereas it reduces substantially the first absorption of dioxin.
- 福岡医学会,Fukuoka Medical Associationの論文
- 2009-05-25
著者
関連論文
- Cytochrome P450 と mEH および UGTとの蛋白質相互作用
- Cholebineによる2,3,4,7,8-Pentachlorodibenzofuran排泄促進
- ダイオキシン類の毒性を安全に軽減できる化合物の候補 : 油症治療を目指した検討
- 3-Methylcholanthrenceおよびantioxiantによるセレン結合性タンパク質の誘導の用量依存性について
- フェノバルビタールにより誘導される2種のモルヒネUDP-グルクロン酸転移酵素分子種